Clinical Investigation Center - Technological Innovation - Inserm 803 - University Hospital France
Grenoble, 38043, France
NCT Number: NCT01335828
Define an ultrasound/elastography benignity criteria in strategy management of a patient population carries one or more thyroid nodules.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2 / Phase 3
Grenoble, 38043, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Echography (all modes) and elastography "ShearWave" system
Time frame: two and half years
For ultrasound and elastography benignity criteria which will be retained, outcome focus on cytoponctions number for benin nodules can be avoided by taking into account this benign criteria
Time frame: two and half years
ROC curves for performance of ultrasound, elastography and their coupling, compared to the reference cytology / histology.
Time frame: two and half years
AdministrateurCIC
Other
"ShearWave" Elastography Interest in the Management of Thyroid Nodules
Acronym: SWETHY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04463719
Endocrine Gland Neoplasms, Endocrine System Diseases
Gainesville, Florida, United States
View Trial DetailsNCT04472026
Endocrine Gland Neoplasms, Endocrine System Diseases
Gainesville, Florida, United States
View Trial DetailsNCT06007859
Endocrine Gland Neoplasms, Endocrine System Diseases
Shandong, China
View Trial DetailsNCT01868750
Calcium Metabolism Disorders, Endocrine Gland Neoplasms
Charlottesville, Virginia, United States
View Trial Details